“Quality of Life in Patients with Bardet-Biedl Syndrome in a Setmelanotide Phase 3 Trial“
Elizabeth Forsythe, Ph.D., Great Ormond Street Institute of Child Health, Faculty of Population Health Sciences, University College London
Poster
“Efficacy and Safety of Open-Label Setmelanotide in Bardet-Biedl Syndrome: A Phase 3 Trial“
Robert Haws, M.D., Clinical Research Center at the Marshfield Clinic Research Institute
Oral presentation slides
“Effects of Setmelanotide on Obesity, Hunger, and Safety in SRC1 Insufficiency“
Sadaf Farooqi, PhD, Wellcome-MRC Institute of Metabolic Science and NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK
Poster
“Effects of Setmelanotide on Obesity, Hunger, and Safety in SH2B1 Deficiency: A Phase 2 Trial“
Jesús Argente, M.D., Ph.D., Professor in the Department of Pediatrics and Pediatric Endocrinology, Universidad Autónoma de Madrid in Spain
Poster
“Frequency of MC4R pathway variants in a large US cohort of patients with severe obesity“
Ida Moeller, ScD, ScM, MMSc, Director of Biomedical Informatics at Rhythm
Poster
“Uncovering Rare Obesity Genetic Testing Program: Overview and Health Care Provider Utilization“
Jill Garrison, Ph.D., Associate Director, Medical Affairs, at Rhythm
Poster
“Biochemical Characterization of Single Minded-1 Missense Variants Associated with Severe Obesity“
Megan Vogel, Ph.D., Scientist, Pre-Clinical Biology at Rhythm
Poster
Rhythm Pharmaceuticals, Inc.
222 Berkeley Street, 12th Floor
Boston, MA 02116